Ramdev, Balkrishna Acharya Ready For ‘Public Apology’; Supreme Court Next Hearing On April 23

New Delhi: The Supreme Court on Tuesday granted a week to Yoga guru Ramdev and Patanjali Ayurved Ltd MD Balkrishna Acharya to take steps to redeem themselves of the alleged contempt after their lawyers offered to issue a public apology for misleading advertisements.

“I am willing to give a public apology,” senior advocate Mukul Rohatgi, appearing for Ramdev and Balkrishna, told a bench of Justices Hima Kohli and Ahsanuddin Amanullah, news agency PTI reported.

The Supreme Court court asked Ramdev and Balkrishna, both of whom were present in the court, to come forward for an interaction with the bench.

“They should feel they have a connect with the court,” the bench said.

The hearing in the matter is underway and the bench is currently interacting with Ramdev.

Ramdev and Balkrishna have tendered an “unconditional and unqualified apology” before the apex court over advertisements issued by the firm making tall claims about the medicinal efficacy of its products.

In two separate affidavits filed in the court, Ramdev and Balkrishna have tendered an unqualified apology for the “breach of the statement” recorded in the November 21 last year order of the apex court.

In the November 21, 2023 order, the top court had noted that counsel representing Patanjali Ayurved had assured it that “henceforth there shall not be any violation of any law(s), especially relating to advertising or branding of products manufactured and marketed by it and, further, that no casual statements claiming medicinal efficacy or against any system of medicine will be released to the media in any form”.

The top court had said Patanjali Ayurved Ltd is “bound down to such assurance”.

The non-observance of the specific assurance and the subsequent media statements irked the apex court, which later issued a notice to them to explain why contempt proceedings be not initiated against them.

Related Posts

  • Pharma
  • September 17, 2024
  • 100 views
One-Third Of India’s 30 Lakh Sepsis Deaths Linked To Antimicrobial Resistance

New Delhi: In 2019, between 3 and 10.4 lakh people in India died due to bacterial antimicrobial resistance (AMR), a condition in which pathogenic bacteria no longer respond to antibiotics,…

  • Pharma
  • September 17, 2024
  • 95 views
DCC Recommends Making Sugam Portal Database Of All Products With Brand Names

New Delhi: The Drugs Consultative Committee (DCC), the advisory committee that advises the Central and state governments on matters that require uniform implementation of drug laws across the country, has recommended…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

One-Third Of India’s 30 Lakh Sepsis Deaths Linked To Antimicrobial Resistance

One-Third Of India’s 30 Lakh Sepsis Deaths Linked To Antimicrobial Resistance

DCC Recommends Making Sugam Portal Database Of All Products With Brand Names

DCC Recommends Making Sugam Portal Database Of All Products With Brand Names

Pharmacist Practicing Without Degree, 35 Types Of Medicines And Surgical Equipments Seized

Pharmacist Practicing Without Degree, 35 Types Of Medicines And Surgical Equipments Seized

All Doctors To Have Unique IDs; NMC Starts Registration On Its New Portal

All Doctors To Have Unique IDs; NMC Starts Registration On Its New Portal

ICMR Signs MoAs To Advance First-In-Human Clinical Trials For Four Promising Molecules

ICMR Signs MoAs To Advance First-In-Human Clinical Trials For Four Promising Molecules

Balaji Action Hsopital now equipped with Robotic System to Revolutionize Surgery

Balaji Action Hsopital now equipped with Robotic System to Revolutionize Surgery